Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy Synergies

AI Briefing

• – Sona Nanotech's tissue analysis results confirm tumor priming, suggesting potential immunotherapy synergies.
• – Follow-up histology data supports the Company's earlier clinical trial results.
• – Results will be presented at an upcoming medical conference, expected to further support the potential of Sona's immunotherapy approach.